12/29/2020 7:06:07 AM
Pluristem Enters Collaboration Agreement With Innovare R&D
12/9/2020 4:09:40 AM
Pluristem To Terminate CLI Study After DMC Recommendation; Study Unlikely To Meet Primary Endpoint
10/13/2020 7:16:15 AM
Pluristem Gets Clearance To Move Forward With Enrollment For Cohort II In Investigator-Led Phase I/II Chronic Graft
8/17/2020 2:43:32 AM
Pluristem Signs Non-binding MOU With Abu Dhabi Stem Cells Center
6/11/2020 7:14:08 AM
Pluristem Activates Clinical Sites And Initiates Enrollment In Phase II Study Of PLX Cells
5/8/2020 6:06:08 AM
Pluristem: FDA Clears IND Application For Phase II COVID-19 Study Of PLX Cells
5/5/2020 10:04:09 AM
Pluristem Announces Pricing Of Registered Direct Offering For $15 Mln
4/13/2020 6:12:48 AM
Pluristem Says Cleared By FDA To Proceed With Treatment In U.S. Under CTAP